PRIM1 and neoplasm: Consistent with our observations in intact tumor-bearing MTB;TetO-HER2/neu;TTC; rYFP mice and in mice bearing orthotopic HER2/neu-Prim1 primary tumors, we did not observe enrichment for TICs among residual tumor cells when injected into mice on doxycycline.